GROUP ONE TRADING, L.P. - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 43 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q1 2020$92,000
-2.1%
5,7940.0%0.00%0.0%
Q4 2019$94,0005,7940.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q1 2020
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 69,100$1,220,0000.02%
MEEDER ASSET MANAGEMENT INC 3,446$61,0000.01%
METROPOLITAN LIFE INSURANCE CO/NY 4,573$80,7590.00%
Ameritas Investment Partners, Inc. 958$17,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 18,173$321,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 7,639$135,0000.00%
NORTHERN TRUST CORP 162,102$2,863,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 12,100$207,0000.00%
RHUMBLINE ADVISERS 15,377$272,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 252,134$4,452,0000.00%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders